Qualigen Therapeutics, Inc. Quarterly Return On Equity in % from Q3 2021 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Qualigen Therapeutics, Inc. annual/quarterly Return On Equity history and growth rate from Q3 2021 to Q2 2023.
  • Qualigen Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2023 was -205 %, a 93.2% decline year-over-year.
  • Qualigen Therapeutics, Inc. annual Return On Equity for 2023 was -931 %, a 608% decline from 2022.
  • Qualigen Therapeutics, Inc. annual Return On Equity for 2022 was -132 %, a 2.41% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -205 -98.8 -93.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -147 -19.2 -15% Jan 1, 2023 Mar 31, 2023
Q4 2022 -132 -3.1 -2.41% Oct 1, 2022 Dec 31, 2022
Q3 2022 -102 -56.8 -125% Jul 1, 2022 Sep 30, 2022
Q2 2022 -106 Apr 1, 2022 Jun 30, 2022
Q1 2022 -128 Jan 1, 2022 Mar 31, 2022
Q4 2021 -128 Oct 1, 2021 Dec 31, 2021
Q3 2021 -45.5 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.